If finalized, the rule would prohibit 503B facilities from compounding these agents under any circumstances, regardless of future market conditions, regardless of whether brand-name supply is adequate
These findings suggest that while bitter substances promise to improve glucose homeostasis, their potential adverse effects beyond the gastrointestinal system warrant careful consideration [196]
A pharmacokinetic study in growth-hormone-deficient patients using a closely related long-acting IGF-1 preparation found a terminal half-life of 5.8 hours for free IGF-1 after subcutaneous dosing, though the exact value for the research-grade LR3 analogue varies by formulation [4]
For mothers of newborns or premature infants, the LactMed database specifically recommends extra caution with tirzepatide pending additional data
Kurosawa, T
The cardioprotective data, while limited to animal models, suggests the peptide may support heart muscle function and survival under stress conditions